Within the tumour, OSCC cells are not the only potential source of inflammatory cytokines; studies in other forms of cancer have shown that tumour associated inflammatory cells also produce cytokines, which can activate transcription factors such as NFκB that activate genes controlling cell survival, proliferation, growth, angiogenesis, invasiveness, and motility (29–31). The gene discussed is NFKB1; the disease is neoplasm.